Diagnostics News and Research

RSS

Genetic Analysis introduces GA-map microarray test for screening of infant gut microbiota

Genetic Analysis AS, the molecular diagnostics company, has launched its GA-map™ microarray test for high throughput screening of infant gut microbiota. At the recent Sackler Colloquium on Microbes and Health in the US, the company presented data from evaluation screens that show its potential as a tool for probing the mechanisms of disease in conditions associated with the gut flora.

1 Dec 2009

MAbs for early detection of cancer

Two sets of recommendations issued earlier this month have revised longstanding guidelines concerning the age at which women should first be tested for breast and cervical cancer and how frequently.

1 Dec 2009

Use of BSGI as adjunct imaging modality for diagnosing breast cancer demonstrated

Dr. Jessica Torrente, Assistant Professor of Radiology at George Washington University Medical Center in Washington, D.C., demonstrated the integration and use of Breast-Specific Gamma Imaging (BSGI) in clinical practice as an adjunct imaging modality for the diagnosis of breast cancer today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

HireRight acquires National Diagnostics

HireRight, Inc., an Altegrity company and a leader in on-demand employment background and drug screening, announced today the close of its acquisition of National Diagnostics, Inc. (NDI), a full-service provider of drug testing and physical exam services that has served U.S. and global employers of all sizes for almost 20 years. Terms of the transaction were not disclosed.

1 Dec 2009

BSGI proves to be an effective adjunct imaging modality for detecting DCIS

Breast-Specific Gamma Imaging (BSGI) has been proven to be a highly sensitive imaging technique for the detection of ductal carcinoma in situ (DCIS), a difficult to diagnose breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers.

30 Nov 2009

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Biomagnetics Diagnostics Corp. (PINK SHEETS:BMGP), a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the Company has finalized a "Patent License Agreement with Los Alamos National Security."

30 Nov 2009

Minerva Biotechnologies grants Clarient exclusive commercializing rights to its MUC1 diagnostic test

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer.

30 Nov 2009

GE Healthcare concentrates on healthymagination to help patients live longer and healthier

Miniaturized ultrasound. Navigation during interventional procedures. Innovations in sound wave imaging. At RSNA 2009, GE Healthcare is finding better ways to see more. And using that information to do more.

30 Nov 2009

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.

30 Nov 2009

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

27 Nov 2009

Vicor Technologies announces implementation of ASP distribution model in cardiology practice

David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced the beta test installation of the company's application service provider (ASP) distribution model in a U.S. cardiology practice.

25 Nov 2009

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.

25 Nov 2009

Roche, Spanish Department of Health to collaborate in Medical Genome Project

Roche and the Department of Health of Junta de Andalucía, Spain have signed an agreement for a cooperation in the Medical Genome Project (MGP), a research project created to analyse the genomes of people with rare diseases and identify the defective gene or genes causing the disease and its behaviour.

From Roche Sequencing and Life Science 24 Nov 2009

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.

23 Nov 2009

STD infections continue to rise among young people

Sexually spread diseases continue to rise, with reported chlamydia cases setting yet another record in 2008, officials at the Centers for Disease Control recently reported. The CDC estimates that approximately 19 million new STD infections occur each year. Approximately half of them occur in young people between 15 to 24 years of age.

23 Nov 2009

Medical students and biomedical scientists to attend 8th World Congress on Trauma, Shock, Inflammation and Sepsis

The 8th World Congress on Trauma, Shock, Inflammation and Sepsis – TSIS 2010 – will take place from March 9th to13th 2010 in the Auditorium Tract of the Ludwig-Maximilians-University, Campus Grosshadern, in Munich/Germany.

23 Nov 2009

EraGen Biosciences to have access to Illumina’s BeadXpress platform

EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.

From Illumina, Inc. 23 Nov 2009

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October: Quest Diagnostics

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services.

From Quest Diagnostics 21 Nov 2009

Quest Diagnostics announces final results of its cash tender offer

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today the final results for its previously announced cash tender offer (the "Tender Offer") to purchase any and all of its 5.125% Senior Notes due 2010 and any and all of its 7.50% Senior Notes due 2011 (collectively, the "Notes").

From Quest Diagnostics 20 Nov 2009

Quest Diagnostics reports sharp downward trends in cocaine and methamphetamine use

New data released today by Quest Diagnostics Incorporated, the nation's leading provider of employment-related drug testing services, reveal that drug testing of hair specimens from employees and job applicants in the general U.S. workforce has tracked sharp downward trends in cocaine and methamphetamine use from 2005 to the first half of 2009 that mirror similar drops shown by urine testing.

From Quest Diagnostics 20 Nov 2009

Diagnostics News and Research

Genetic Analysis introduces GA-map microarray test for screening of infant gut microbiota

MAbs for early detection of cancer

Use of BSGI as adjunct imaging modality for diagnosing breast cancer demonstrated

HireRight acquires National Diagnostics

BSGI proves to be an effective adjunct imaging modality for detecting DCIS

Biomagnetics Diagnostics announces Patent License Agreement with Los Alamos National Security

Minerva Biotechnologies grants Clarient exclusive commercializing rights to its MUC1 diagnostic test

GE Healthcare concentrates on healthymagination to help patients live longer and healthier

VIDA Diagnostics and Veran Medical to develop and market endobronchial lung navigation and biopsy system

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

Vicor Technologies announces implementation of ASP distribution model in cardiology practice

FDA provides marketing clearance for Prodesse's ProParaflu+ assay

Roche, Spanish Department of Health to collaborate in Medical Genome Project

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

STD infections continue to rise among young people

Medical students and biomedical scientists to attend 8th World Congress on Trauma, Shock, Inflammation and Sepsis

EraGen Biosciences to have access to Illumina’s BeadXpress platform

Rates of infection by the 2009 H1N1 influenza virus may have peaked in late October: Quest Diagnostics

Quest Diagnostics announces final results of its cash tender offer

Quest Diagnostics reports sharp downward trends in cocaine and methamphetamine use

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News